Literature DB >> 18839277

STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251 cells.

Guang-hui Li1, Hong Wei, Zheng-tang Chen, Sheng-qing Lv, Chang-lin Yin, Dong-lin Wang.   

Abstract

Glioblastoma multiforme (GBM), the most common type of central nervous system tumor in humans, is highly proliferative and resistant to apoptosis associated with genetic mutations that deregulate cell cycle. Signal transduction and activation of transcription 3 (Stat3) is a key signal transduction protein that mediated signaling by cytokines and contributed to oncogenesis. It is constitutively activated in numerous cancers including glioblastoma. To determine the effect on proliferation and differentiation of glioblastoma U251 cells after inhibiting STAT3 expression by RNAi, STAT3 gene was silenced with lentivirus vector in U251 cells. We demonstrate that a lentivirus-based shRNA vector had highly infecting efficiency to U251 cells and lentivirus vector-mediated RNAi significantly suppressed Stat3 expression and activation in U251 cells. Knockdown of STAT3 expression by RNAi suppressed the growth and induced apoptosis of U251 cells by down-regulating expression of Bcl-2. It was found that the cell proportion of G0/G1 phase significantly increased after silencing Stat3 by down-regulating expression of cyclin D1. Knockdown of Stat3 also induces morphological changes of U251 cell. It increases significantly expression of myelin basic protein (MBP) in U251 cells. This study demonstrates that STAT3 silencing with lentivirus effectively inhibits STAT3 gene expression and activation. Stat3 is associated with the survival, growth and differentiation of U251 cells. Lentivirus vector-mediated RNAi may be serve as a novel therapeutic strategy for treatment of GBM with expression constitutively and activation of STAT3 gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18839277     DOI: 10.1007/s11060-008-9696-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  37 in total

Review 1.  Malignant glioma: genetics and biology of a grave matter.

Authors:  E A Maher; F B Furnari; R M Bachoo; D H Rowitch; D N Louis; W K Cavenee; R A DePinho
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

Review 2.  What does Stat3 do?

Authors:  David E Levy; Chien-kuo Lee
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 3.  Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis.

Authors:  James V Alvarez; David A Frank
Journal:  Cancer Biol Ther       Date:  2004-11-22       Impact factor: 4.742

4.  Stat3 activation by Src induces specific gene regulation and is required for cell transformation.

Authors:  J Turkson; T Bowman; R Garcia; E Caldenhoven; R P De Groot; R Jove
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

5.  Overexpression of SOCS3 inhibits astrogliogenesis and promotes maintenance of neural stem cells.

Authors:  Fang Cao; Ryuji Hata; Pengxiang Zhu; Yong-Jie Ma; Junya Tanaka; Yasushi Hanakawa; Koji Hashimoto; Michio Niinobe; Kazuaki Yoshikawa; Masahiro Sakanaka
Journal:  J Neurochem       Date:  2006-07       Impact factor: 5.372

6.  Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.

Authors:  Shaik Ohidar Rahaman; Michael A Vogelbaum; S Jaharul Haque
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

7.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

Authors:  R Catlett-Falcone; T H Landowski; M M Oshiro; J Turkson; A Levitzki; R Savino; G Ciliberto; L Moscinski; J L Fernández-Luna; G Nuñez; W S Dalton; R Jove
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

8.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Authors:  Michelle A Blaskovich; Jiazhi Sun; Alan Cantor; James Turkson; Richard Jove; Saïd M Sebti
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

9.  BCL2 antisense reduces prostate cancer cell survival following irradiation.

Authors:  Susan L Scott; Roger Higdon; Laurel Beckett; Xu-Bao Shi; Ralph W deVere White; John D Earle; Paul H Gumerlock
Journal:  Cancer Biother Radiopharm       Date:  2002-12       Impact factor: 3.099

10.  Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo.

Authors:  Li-fang Gao; Lian-ji Wen; Hao Yu; Ling Zhang; Yan Meng; Yue-ting Shao; De-qi Xu; Xue-jian Zhao
Journal:  Acta Pharmacol Sin       Date:  2006-03       Impact factor: 6.150

View more
  15 in total

1.  Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion.

Authors:  Utpal K Mukhopadhyay; Patrick Mooney; Lilly Jia; Robert Eves; Leda Raptis; Alan S Mak
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

2.  Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3.

Authors:  Te Du; Guoying Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-20       Impact factor: 11.205

3.  Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.

Authors:  Olga A Guryanova; Qiulian Wu; Lin Cheng; Justin D Lathia; Zhi Huang; Jinbo Yang; Jennifer MacSwords; Christine E Eyler; Roger E McLendon; John M Heddleston; Weinian Shou; Dolores Hambardzumyan; Jeongwu Lee; Anita B Hjelmeland; Andrew E Sloan; Markus Bredel; George R Stark; Jeremy N Rich; Shideng Bao
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

4.  Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.

Authors:  Yan Liu; Pui-Kai Li; Chenglong Li; Jiayuh Lin
Journal:  J Biol Chem       Date:  2010-06-18       Impact factor: 5.157

5.  The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo.

Authors:  Sutapa Banerjee; Jonathan N Byrd; Scott M Gianino; Scott E Harpstrite; Fausto J Rodriguez; Robert G Tuskan; Karlyne M Reilly; David R Piwnica-Worms; David H Gutmann
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

6.  STAT3 silencing inhibits glioma single cell infiltration and tumor growth.

Authors:  Maike Priester; Ekaterini Copanaki; Vida Vafaizadeh; Sandra Hensel; Christian Bernreuther; Markus Glatzel; Volker Seifert; Bernd Groner; Donat Kögel; Jakob Weissenberger
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

7.  Role of activating transcription factor 3 in the synthesis of latency-associated transcript and maintenance of herpes simplex virus 1 in latent state in ganglia.

Authors:  Minfeng Shu; Te Du; Grace Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

8.  The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.

Authors:  Selvaraju Veeriah; Cameron Brennan; Shasha Meng; Bhuvanesh Singh; James A Fagin; David B Solit; Philip B Paty; Dan Rohle; Igor Vivanco; Juliann Chmielecki; William Pao; Marc Ladanyi; William L Gerald; Linda Liau; Timothy C Cloughesy; Paul S Mischel; Chris Sander; Barry Taylor; Nikolaus Schultz; John Major; Adriana Heguy; Fang Fang; Ingo K Mellinghoff; Timothy A Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

9.  Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.

Authors:  Irina Kiprianova; Janina Remy; Nelli Milosch; Isabelle V Mohrenz; Volker Seifert; Achim Aigner; Donat Kögel
Journal:  Neoplasia       Date:  2015-07       Impact factor: 5.715

10.  The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death.

Authors:  G Wang; J J Wang; X L Chen; S M Du; D S Li; Z J Pei; H Lan; L B Wu
Journal:  Cell Death Dis       Date:  2013-08-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.